These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 22918215)

  • 1. Risk factors of local oropharyngeal and laryngeal adverse effects from use of single inhaled corticosteroids and long-acting beta-agonists.
    Horita N; To M; Araki K; Haruki K; To Y
    Allergol Int; 2012 Dec; 61(4):583-8. PubMed ID: 22918215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids.
    Salpeter SR
    Expert Opin Drug Saf; 2010 May; 9(3):407-19. PubMed ID: 20408768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events.
    Salpeter SR; Wall AJ; Buckley NS
    Am J Med; 2010 Apr; 123(4):322-8.e2. PubMed ID: 20176343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
    Gibson PG; Powell H; Ducharme FM
    J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma.
    Fahy JV; Boushey HA
    Clin Chest Med; 1995 Dec; 16(4):715-33. PubMed ID: 8565410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
    Kiri VA; Fabbri LM; Davis KJ; Soriano JB
    Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of long-acting β agonists for the treatment of asthma: clearing the air.
    Rodrigo GJ; Castro-Rodríguez JA
    Thorax; 2012 Apr; 67(4):342-9. PubMed ID: 21515554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma.
    Buhl R
    Allergy; 2006 May; 61(5):518-26. PubMed ID: 16629778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma.
    Perrin K; Williams M; Wijesinghe M; James K; Weatherall M; Beasley R
    J Allergy Clin Immunol; 2010 Sep; 126(3):505-10. PubMed ID: 20816187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction between inhaled corticosteroids and long-acting beta-2-agonists].
    Kardos P
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S386-9. PubMed ID: 19941242
    [No Abstract]   [Full Text] [Related]  

  • 14. [Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?].
    Buhl R
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S381-5. PubMed ID: 19941241
    [No Abstract]   [Full Text] [Related]  

  • 15. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD).
    Cecere LM; Slatore CG; Uman JE; Evans LE; Udris EM; Bryson CL; Au DH
    COPD; 2012 Jun; 9(3):251-8. PubMed ID: 22497533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
    Gagnon YM; Levy AR; Spencer MD; Hurley JS; Frost FJ; Mapel DW; Briggs AH
    Respir Med; 2005 Dec; 99(12):1534-45. PubMed ID: 16291076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pattern of risk of myocardial infarction in patients taking asthma medication: a study with the General Practice Research Database.
    Zhang B; de Vries F; Setakis E; van Staa TP
    J Hypertens; 2009 Jul; 27(7):1485-92. PubMed ID: 19491706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug utilization and asthma control among young Danish adults with asthma. Analyses of trends and determinants.
    Davidsen JR
    Dan Med J; 2012 Aug; 59(8):B4501. PubMed ID: 22849986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.
    Mapel DW; Hurley JS; Roblin D; Roberts M; Davis KJ; Schreiner R; Frost FJ
    Respir Med; 2006 Apr; 100(4):595-609. PubMed ID: 16199151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.